Teva Pharmaceutical Industries Ltd (TEVA, TEVJF)
CIK 818686 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Teva Pharmaceutical Industries Ltd.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 11, 2026 | 424B5 | 0001193125-26-389382 |
| Sep 11, 2026 | 8-K | 0001193125-26-389264 |
| Sep 10, 2026 | FWP | 0001193125-26-387100 |
| Sep 10, 2026 | FWP | 0001193125-26-387112 |
| Sep 8, 2026 | 424B5 | 0001193125-26-384343 |
| Sep 3, 2026 | 8-K | 0001193125-26-381879 |
| Sep 3, 2026 | 8-K | 0001193125-26-381899 |
| Aug 25, 2026 | 4 | 0001193125-26-365107 |
| Aug 25, 2026 | 4 | 0001193125-26-365116 |
| Aug 19, 2026 | 4 | 0001193125-26-356853 |
| Aug 17, 2026 | 144 | 0001973379-26-000296 |
| Aug 10, 2026 | 4 | 0001193125-26-341086 |
| Aug 5, 2026 | 4 | 0001193125-26-335026 |
| Aug 5, 2026 | 4 | 0001193125-26-335012 |
| Aug 3, 2026 | 144 | 0001973379-26-000273 |
| Aug 3, 2026 | 144 | 0001973379-26-000274 |
| Jul 29, 2026 | 8-K | 0001171843-26-004974 |
| Jul 29, 2026 | 10-Q | 0001193125-26-323619 |
| Jul 29, 2026 | F-6 POS | 0001193805-26-001006 |
| Jun 22, 2026 | 4 | 0001193125-26-277490 |
| Jun 18, 2026 | 144 | 0001973379-26-000248 |
| Jun 16, 2026 | 4 | 0001193125-26-271862 |
| Jun 11, 2026 | 144 | 0001973379-26-000227 |
| Jun 8, 2026 | 4 | 0001193125-26-261701 |
| Jun 8, 2026 | 4 | 0001193125-26-261712 |